Related by context. All words. (Click for frequent words.) 63 preoperative chemotherapy 62 advanced adenomas 62 glioma tumors 62 differentiated thyroid 61 sentinel nodes 60 axillary nodes 60 postoperative chemotherapy 60 sentinel node biopsy 60 nonsmall cell lung cancer 60 removed laparoscopically 60 medically inoperable 60 Radical prostatectomy 60 recurrent NSCLC 59 precancerous polyp 59 underarm lymph nodes 59 neoadjuvant therapy 59 sleeve lobectomy 59 HER2 positive cancers 59 recurrent metastatic 59 pancreatic resection 59 distant metastases 59 bladder tumors 59 lymph node removal 59 underwent surgical resection 59 intraductal 59 sentinel lymph node biopsy 59 peritoneal cancer 59 angioplasties stents 58 tumor recurrence 58 axillary dissection 58 adjuvant radiotherapy 58 radical nephrectomy 58 thoracoscopic lobectomy 58 Hepatocellular Carcinoma HCC 58 unresectable 58 metastatic GIST 58 GIST tumors 58 basal cell cancers 58 coronary artery bypass grafts 58 axillary lymph node dissection 58 hormone receptor positive 58 microalbumin test 58 ductal carcinomas 57 axillary node dissection 57 colorectal lung 57 adjuvant radiation 57 epithelial ovarian 57 recurrent glioblastoma multiforme 57 Metastatic colorectal cancer 57 raloxifene Evista 57 Barrett mucosa 57 unresectable tumors 57 HER2 negative 57 pelvic lymph nodes 57 advanced adenoma 57 para aortic 57 radioiodine therapy 57 salpingo oophorectomy 57 melanoma lesions 57 ductal breast cancer 57 metastatic gastric 57 malignant neoplasm 57 non squamous NSCLC 57 metastatic RCC 57 abdominal ultrasounds 57 hepatic metastases 57 ERBITUX Cetuximab 57 prostates removed 57 CIN3 57 distal colon cancer 57 esophageal resection 57 axillary lymph nodes 57 ALND 57 Menaflex implanted 57 undergone radical prostatectomy 57 micrometastases 57 metastatic colorectal 56 benign nodules 56 Mohs micrographic surgery 56 stage IIIB IV 56 invasive carcinoma 56 Hurthle cell 56 bilateral oophorectomy 56 colorectal bowel 56 atypical ductal hyperplasia 56 lymph node dissection 56 bronchogenic carcinoma 56 Basal cell 56 Colon polyps 56 HNSCC 56 core needle biopsy 56 underwent resection 56 advanced unresectable 56 intravenous bisphosphonates 56 cystectomy 56 catheter angiography 56 metastatic HER2 positive 56 malignant pleural mesothelioma 56 postoperative pathology 56 rates Tangka 56 KRAS mutations occur 56 pancreatic adenocarcinoma 56 hormone receptor negative 56 Radio Frequency Ablation 56 basal cell cancer 56 anastrazole 56 diagnostic angiography 56 surgical biopsy 56 gynecologic oncologists 56 papillary renal cell carcinoma 56 stage IIIB 56 resectable 56 curative resection 56 symptomatic BPH 56 severe exacerbations 56 atrial ablation 56 Donated organs 56 reinterventions 56 Squamous 56 taxane chemotherapy 56 nonmelanoma skin cancers 56 GnRH agonists 56 revascularization procedures 56 laparoscopically assisted 56 colorectal polyp 56 EUS FNA 56 laparoscopic hysterectomies 56 cisplatin chemotherapy 56 squamous cell cancers 56 Circulating tumor cells 55 lung metastases 55 Urinary infections 55 undergo prostate biopsy 55 preventive mastectomy 55 revascularization procedure 55 completely resected 55 cilostazol 55 stage IIIA 55 radiation chemoradiation 55 System IPSS 55 Nothing Wadden 55 peritoneal carcinomatosis 55 abdominal hysterectomy 55 lung resections 55 Adjuvant chemotherapy 55 breast conserving lumpectomy 55 invasive ductal carcinoma 55 stomach stapling surgeries 55 deCODE ProstateCancer TM 55 invasive ductal breast cancer 55 colon resection 55 TRUS biopsy 55 progesterone receptor negative 55 Papillary 55 colon esophageal 55 calcified plaques 55 Benign tumors 55 deep venous thromboses 55 malignant polyps 55 HER2 positive tumors 55 bowel cancers 55 Sirtex SIR Spheres microspheres 55 endometriosis ovarian cysts 55 treated nonsurgically 55 needle biopsies 55 meningiomas 55 symptomatic carotid stenosis 55 lobular cancer 55 preventive mastectomies 55 colorectal cancer liver metastases 55 nonmetastatic 55 ano genital warts 55 metastatic lung cancer 55 liver resection 55 ovarian pancreatic 55 distant metastasis 55 Squamous cell 55 thymectomy 55 Metastatic prostate cancer 55 hip resurfacing arthroplasty 55 undergone splenectomy 55 Colorectal cancer screening 55 colorectal neoplasms 55 chemoradiation therapy 55 PR interval prolongation 54 cranial radiation 54 atypical hyperplasia 54 pancreatic lung 54 CABG surgeries 54 hepatectomy 54 malignant cancerous 54 hypervascular tumors 54 chemoradiation 54 BRCA mutation carriers 54 preoperative radiotherapy 54 postoperative infections 54 Isolaz procedures 54 percutaneous biopsy 54 inguinal hernia repair 54 chronic ITP patients 54 breast cancer recurrences 54 metastatic neuroendocrine tumors 54 HER2 expression 54 lymphocytosis 54 radiofrequency ablation RFA 54 untreated metastatic melanoma 54 esophagectomy 54 radical prostatectomy 54 GISTs 54 testicular cancers 54 prescribed statins 54 beam radiotherapy 54 liver metastases 54 UPPP 54 metastatic HER2 negative 54 prostatectomies 54 localized prostate 54 lymph node involvement 54 Rectal cancer 54 skeletal metastases 54 intraperitoneal therapy 54 squamous cell 54 tamoxifen Nolvadex ® 54 postoperative mortality 54 email sicity@intrstar.net 54 Her2 positive 54 Multaq tablets 54 excisional biopsy 54 osteosarcomas 54 abnormal Pap 54 oropharyngeal cancer 54 Squamous cell carcinomas 54 inoperable tumors 54 prophylactic cranial irradiation 54 radiation therapy 54 Malignant tumors 54 recurrent VTE 54 surgical biopsies 54 pulmonary metastases 54 leukemia APL 54 chlamydial infection 54 undergo mastectomy 54 colorectal adenoma 54 severe hepatic dysfunction 54 HBeAg negative 54 SUVmax 54 Recurrences 54 total thyroidectomy 54 Estrogen receptor positive 54 patients undergoing CABG 54 carotid endarterectomies 54 cisplatin resistant 54 invasive coronary angiography 54 serous ovarian cancer 54 BRCA1 mutation carriers 54 screening colonoscopies 54 curable cancers 54 breast carcinoma 54 Radiofrequency ablation 54 EGFR mutation positive 54 perioperative mortality 54 occult metastases 54 metastatic bladder 54 lung cancer NSCLC 54 histologically confirmed 54 vaginal hysterectomies 54 contralateral breast 54 colorectal liver metastases 54 advanced hepatocellular carcinoma 54 lung esophageal 54 NATRECOR R 54 anthracycline taxane 54 radical cystectomy 54 DCIS lesions 54 groin hernias 54 balloon angioplasties 54 cervical carcinoma 54 polyp recurrence 54 conventional angiography 54 asymptomatic carotid stenosis 54 renal cell carcinomas 54 SLNB 54 nodal metastasis 54 hepatorenal syndrome 54 malignant growths 54 electrical cardioversion 54 papillary carcinoma 54 ASPS statistics 54 reoperations 54 differently Widmer Schlump 54 small keyhole incisions 54 surgically resectable 54 malignant neoplasms 54 estrogen receptor positive 54 relapsing remitting MS RRMS 54 renal tumors 54 precancerous lesion 54 locoregional 54 mCRC acneform rash 54 PCIs 54 intravesical therapy 54 adenomatous polyps 54 extracapsular extension 53 prescribed CRESTOR 53 basal cell carcinoma squamous 53 extracolonic findings 53 chemotherapy cisplatin 53 abnormal mammogram 53 lymph node metastases 53 Mitomycin C 53 Like Waitz Aanesen 53 complex fusions 53 lenalidomide Revlimid R 53 invasive lobular 53 undergo lumpectomy 53 performed laparoscopically 53 eribulin 53 wedge resection 53 oral clodronate 53 EBUS 53 situ LCIS 53 DEXA scans 53 intestinal polyps 53 clot dissolving drugs 53 PSA nadir 53 Glioblastoma Multiforme GBM 53 ductal cancer 53 neoadjuvant chemotherapy 53 benign prostatic hyperplasia enlarged 53 armpit lymph nodes 53 breast conserving 53 histopathologic examination 53 adult chronic ITP 53 prostate radical prostatectomy 53 nonsurgical treatments 53 folic acid takers 53 debulking surgery 53 abnormal mammograms 53 pre cancerous polyps 53 stenting procedures 53 repigmentation 53 advanced epithelial ovarian 53 Gliadel Wafer 53 bladder cancers 53 ER CHOP 53 radiosensitive 53 node metastases 53 clot busting therapy 53 frequently benign tumor 53 soft tissue sarcomas 53 reduce serum phosphate 53 minimally symptomatic 53 neuroendocrine cancers 53 bladder prostate 53 relapsed MM 53 neoadjuvant radiation 53 grade gliomas 53 endometrial ovarian 53 lobular carcinoma 53 colon adenomas 53 undergoing hysterectomy 53 underwent CABG 53 non resectable metastatic 53 windpipe transplants 53 cervical cancer precursors 53 visit www.rtanswers.org 53 kidney urologic 53 K ras mutations 53 BEXXAR Therapeutic Regimen 53 lung tumors 53 PLX STROKE targeting 53 resected 53 EBRT 53 underwent coronary angiography 53 Platinol ® cisplatin 53 squamous cell cancer 53 Biopsies 53 HER2 amplification 53 BRCA2 gene mutation 53 metastatic lymph nodes 53 resections 53 recurrent colorectal cancer 53 metachronous 53 intrahepatic bile duct 53 pulmonary artery banding 53 ICD implantation 53 Pancreatic neuroendocrine tumors 53 Spectranetics laser 53 surgical excision 53 palliative radiotherapy 53 sentinel node 53 verum acupuncture 53 postoperative infection 53 PSADT 53 gastric corpus 53 ovarian endometrial 53 MMSE scores 53 basal cell skin 53 cutaneous squamous cell carcinoma 53 ocular melanoma 53 poorer prognosis 53 NYP-NEWS 53 PAH afflicts approximately 53 hormonal therapy 53 thyroid nodules 53 coinfected patients 53 adenoma 53 endocrine therapies 53 carotid stenosis 53 HCV antibody 53 neurologic complications 53 gynecologic procedures 53 BRCA2 mutations 53 pT3 53 squamous cell lung cancer 53 alkylating agents 53 post thrombotic syndrome 53 cytoreduction 53 pCR 53 operable breast cancer 53 anaplastic 53 upper endoscopy 53 adenocarcinomas 53 metastatic relapsed 53 GRNOPC1 contains 53 EGFR mutation 53 bilateral orchiectomy 53 cytotoxic therapies 53 Thal Dex 53 biochemical recurrence 53 colon capsule endoscopy 52 abnormal Pap smears 52 RLS sufferers 52 endarterectomy 52 pleural mesothelioma 52 oligodendrogliomas 52 hepatitis C genotype 52 metastatic tumors 52 TURP 52 histologically proven 52 Breast MRIs 52 mammographies 52 histologic subtype 52 sigmoidoscopies 52 RBC transfusions 52 membranous nephritis 52 tamoxifen therapy 52 inhaled glucocorticoids 52 clinically localized prostate 52 CMV disease 52 ovarian lung 52 undergone hysterectomy 52 Islet cells 52 leukemias lymphomas 52 metastatic prostate 52 heterotaxy 52 squamous cell carcinoma SCC 52 systemic invasive fungal 52 PET CT scanning 52 surgical resection cavity 52 pharynx larynx 52 colorectal adenocarcinoma 52 coronary arteriography 52 Stereotactic body 52 precancers 52 GBM tumors 52 neuroblastomas 52 familial pancreatic cancer 52 needle aspiration 52 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 52 placebo dexamethasone 52 aldosterone antagonist 52 Zevalin consolidation 52 HER2 positive 52 transrectal ultrasound guided 52 Surgical excision 52 mutated K ras 52 prostate biopsy 52 perioperatively 52 female endoscopist 52 Chlamydia infection 52 prostatectomy 52 metastatic basal cell 52 concurrent chemoradiation 52 B7 H3 52 pneumonectomy 52 dacarbazine chemotherapy 52 advanced malignant hepatic 52 Outages ranged 52 catheter ablations 52 deCODE BreastCancer TM 52 renal carcinoma 52 orchiectomy 52 spine fusions 52 oral squamous cell 52 Hormonal therapy 52 BRCA mutation 52 locoregional recurrence 52 lung resection 52 corticosteroid therapy 52 chemoradiotherapy 52 pancreas transplants 52 advanced medullary thyroid 52 radical prostatectomies 52 anaplastic astrocytoma AA 52 knee arthroscopies prostate biopsies 52 implant stents 52 plus dacarbazine 52 recurrent prostate cancer 52 gallstone disease 52 laparoscopic adjustable gastric banding 52 pre cancerous lesion 52 BCG refractory 52 Moyamoya disease 52 guaiac 52 axillary lymph node 52 sentinel lymph node 52 faulty BRCA genes 52 cancerous ovarian cyst 52 DXA scan 52 Sentinel Lymph Node Biopsy 52 mutated KRAS gene 52 premalignant 52 cervical lymph nodes 52 biliary tract cancer 52 SilverHawk Plaque Excision System 52 mediastinal lymph nodes 52 carotid artery blockage 52 mediastinoscopy 52 orchitis 52 venous thromboembolisms 52 #.#ng/ml 52 prostate biopsies 52 urothelial cancer 52 Genital HPV 52 cytoreductive surgery 52 carotid surgery 52 Uterine cancer 52 breast endometrial 52 lung ovary 52 gadobutrol 52 multimodality therapy 52 EXJADE 52 cerebral angiography 52 motesanib 52 fibrocystic disease 52 postmenopausal hormones 52 nasopharyngeal carcinoma 52 uveal melanoma 52 coronary angiograms 52 Fetal heartbeats 52 endometrial biopsy 52 Bladder stones 52 CYPHER Stent 52 prophylactic mastectomy 52 oncologic outcomes 52 conventional colonoscopy 52 CTEPH 52 pelvic lymphadenectomy 52 renal transplants 52 adverse cytogenetics 52 metastatic lesions 52 Antibiotic resistant infections 52 allogeneic bone marrow 52 meningioma 52 hepatocellular carcinomas 52 endometrial hyperplasia 52 perioperative morbidity 52 stereotactic radiotherapy 52 lymph node biopsies 52 prostate TURP 52 prostate abnormalities 52 TMP SMX 52 thoracic surgeries 52 Surgical resection 52 narcolepsy cataplexy 52 malignant polyp 52 estrogen receptor negative 52 prescribed opioids 52 postoperative morbidity 52 intestinal metaplasia 52 Flexi Scope 52 advanced neoplasia 52 cancerous polyps 52 colon growths 52 curability 52 spiral CTs 52 cytotoxic therapy 52 detecting precancerous 52 digital rectal exams 52 fibrate drugs 52 prostate cancer metastases 52 chemoembolization 52 hormone deprivation 52 metastatic disease 52 metastases 52 ASCUS 52 pelvic malignancies 52 nonmelanoma 52 nephrectomies 52 biliary tract 52 chemo radiotherapy 52 computerized tomography scans 52 biochemical relapse 52 gauge vitrectomy 51 glomerular filtration 51 tumors 51 extracolonic 51 NovoTTF #A System 51 less invasively 51 Sentinel node biopsy 51 primary immunodeficiency PI 51 laparoscopic appendectomy 51 Konashenkov allegations 51 NMT minimally invasive 51 concomitant antibiotics 51 Accelerated Partial Breast Irradiation 51 Cystoscopy 51 dysplastic lesions 51 lung nodules 51 invasive cervical cancer 51 sigmoidoscopy 51 clinically detectable 51 methotrexate therapy 51 autologous SCT 51 prophylactic mastectomies 51 untreated metastatic pancreatic 51 eribulin mesylate 51 angioplasty stenting 51 gastrointestinal tumors GIST 51 gastric bypasses 51 precursor lesions 51 adjuvant therapies 51 bowel resection 51 biopsies 51 Malignant gliomas 51 VATS lobectomy 51 precaution Wiehle 51 undergoing coronary angiography 51 nonmetastatic prostate cancer 51 intraoperative complications 51 Transurethral Resection 51 Tumors shrank 51 lymph nodes 51 fibroadenomas 51 cervical lymph node 51 diagnose coronary artery 51 subclinical hyperthyroidism 51 esophagogastric junction 51 perforated colons 51 candidemia 51 underwent brachytherapy 51 tumor resection 51 ADPKD 51 axillary node 51 partial nephrectomy 51 colonoscopy detects precancerous polyps 51 Ectopia Cordis 51 MMP inhibitors 51 fibrinolytic therapy 51 invasive ductal 51 unruptured aneurysms 51 Fogelberg songs 51 Implantable cardioverter defibrillators 51 polyps growths 51 aromatase inhibitor therapy 51 portal vein thrombosis 51 metastatic dermatofibrosarcoma protuberans DFSP 51 ovulation induction 51 situ CIS 51 hamartomas 51 immuno compromised patients 51 malignant pleural effusion 51 lobular carcinomas 51 gastrointestinal stromal tumor GIST 51 relapsed SCLC 51 ruptured aneurysms 51 ASPS comprises 51 transfusion syndrome 51 Squamous Cell 51 Balloon angioplasty 51 malignant ovarian 51 ß blockers 51 CIN3 + 51 Glaxo Tykerb 51 treated nonoperatively 51 osteoporotic compression fractures 51 Angioplasties 51 hormonally sensitive 51 gemcitabine chemotherapy 51 colorectum 51 distal colon 51 CIN2 + 51 seminoma 51 incisional biopsy 51 commercialize deforolimus 51 malignant prostate 51 abnormal pap smear 51 HER2 positive breast 51 androgen deprivation 51 Coronary artery bypass graft 51 Squamous cell cancer 51 Wartime PTSD 51 intra abdominal abscess 51 prescribe statins 51 endoscopic retrograde cholangiopancreatography 51 BRCA mutations 51 Stereotactic radiosurgery 51 anthracycline therapy 51 histologies 51 undergoing CABG 51 uterine perforation 51 vaginal hysterectomy 51 cervical lesions 51 metastatic pancreatic 51 endoscopic ultrasound 51 Testosterone gel 51 anal cancers 51 lung liver pancreas 51 intravesical infusion therapy 51 uterine fibroid embolization 51 percutaneous drainage 51 pelvic ultrasound 51 trans urethral resection 51 revascularized 51 SILS procedure 51 external beam radiotherapy 51 Iodine counteracts 51 nonadherent 51 HIPEC 51 diffuse gastric 51 Intravenous immunoglobulin 51 FDA Approves Novel 51 undergone hysterectomies 51 lymphomas leukemias 51 Argentex Pinguino property 51 invasive biopsy 51 gastrointestinal stromal tumors 51 FOLFIRI alone 51 Golfer Ballesteros 51 aortic necks 51 overexpress HER2 51 antiretroviral naïve 51 breast carcinomas 51 ARIXTRA 51 dalteparin 51 pulsatile flow 51 malignant lesions 51 coronary blockages 51 invasive fungal 51 androgen suppression therapy 51 median sternotomy 51 cystoscopic 51 endometrial cancers 51 endometrial kidney 51 extracapsular 51 melanoma tumors 51 Subgroup analyzes 51 acute STEMI 51 SCIg 51 postprocedure 51 Renal impairment 51 mitomycin C 51 cytoreductive nephrectomy 51 ICDs implanted 51 gemcitabine carboplatin 51 low expressors 51 underwent prostate biopsy 51 Stereotactic Body Radiation Therapy 51 gefitinib Iressa 51 metastatic melanomas 51 postoperative atrial fibrillation 51 invasive angiography 51 glycoprotein IIb IIIa inhibitors 51 Fatalistic kids 51 underwent radical prostatectomy 51 abnormal growths 51 noncardiac surgery 51 metastatic malignant 51 recurrent ovarian 51 invasive catheter 51 Chest x rays 51 methotrexate monotherapy 51 carotid endarterectomy 51 screening colonoscopy 51 nonsquamous 51 TNF antagonist 51 Glioblastoma multiforme GBM 51 GnRH agonist 51 metastatic liver 51 uterine cancers 51 MELD scores 51 thiazide diuretics 51 arteriovenous malformations 51 Related Anemia 51 baseline LDH 51 unresectable liver cancer 51 Watchful waiting 51 thymoma 51 transurethral resection 51 carcinoma HCC 51 colectomy 51 Allovectin 7 ® 51 impair fertility 51 Bayer HealthCare Onyx Pharmaceuticals 51 estrogen progestin combination 51 diagnosed glioblastoma multiforme 51 seminomas 51 SEISMIC Trial 51 interferon ribavirin 51 synthetic grafts 51 Brain metastases 51 Gabriel Mollet 51 Postoperative complications 51 chronic GVHD 51 FOLFOX4 51 lobectomies 51 breast reconstructions 51 polypoid lesions 51 sentinel lymph nodes 51 endoscopic ultrasound EUS 51 esophageal cancers 51 neuroendocrine tumors 51 colon rectal 51 balloon hem minidresses 51 duplex ultrasonography 51 liver biopsies 51 precancerous condition 51 Immunosuppressive drugs 51 esophagus colon 51 Best Orchestrations Doug Besterman 51 thoracotomy 51 ICSI cycles 51 gastrointestinal cancers 51 noncardiovascular mortality 51 lobules 51 inhaled bronchodilators 51 beta blocker therapy 51 neoplastic cells 51 Dr. Assa Amit 51 endometrial carcinoma 50 esthesioneuroblastoma rare form 50 psoriatic arthritis PsA 50 inhibit platelet function 50 prostate cancers 50 chronic periodontitis 50 KRAS status 50 implanted pacemakers 50 parathyroid carcinoma 50 oophorectomy 50 pelvic examinations 50 gastric carcinoma 50 MACCE 50 thrombocytopenic 50 gastrointestinal stromal 50 AF ablation procedures 50 liver metastasis 50 pituitary adenomas 50 bariatric procedures 50 diseased valves 50 prostate carcinoma 50 adjuvant chemotherapy 50 osteoporotic vertebral fractures 50 chemoresistant 50 immune suppressing medication 50 epithelial tumors 50 intracranial atherosclerosis 50 transthoracic 50 BRAF mutation 50 prophylactic antibiotics 50 hyperplasia BPH 50 noncardiac 50 ductal lavage 50 benign breast 50 prostate bladder 50 beta carotene supplementation 50 hepatocellular cancer 50 pacemakers implanted 50 stenoses 50 treat brain aneurysms 50 bowel polyps 50 nonnucleoside reverse transcriptase inhibitors 50 antiplatelet medications 50 Arthur Labovitz 50 microdebrider 50 HER2 positive metastatic breast 50 Meningiomas 50 Liver transplants 50 Radiation therapy 50 postoperative bleeding 50 Dialysis Outcomes 50 bone grafting procedures 50 lymphadenectomy 50 Computed tomography 50 vulvar cancer 50 curative therapy 50 ovaries fallopian tubes 50 hypermethylated 50 specific antigen PSA 50 bile duct cancers 50 cancerous lesions 50 basal cell nevus syndrome 50 PegIntron 50 lung nodule 50 TYSABRI therapy 50 skin sparing mastectomy 50 intravitreal injections 50 undergoing cardiac catheterization 50 Thyroid nodules 50 e mail jplanck@thedailymail.net 50 intraperitoneal chemotherapy 50 IFN alfa 50 prior chemotherapy regimens 50 Intraoperative Radiation Therapy IORT 50 blotchy skin bumps 50 Heavy snorers 50 AGILECT R 50 Pap smear screening 50 bladder cervix 50 epithelial ovarian cancer 50 pancreas esophagus 50 CYT# potent vascular disrupting 50 awaiting kidney transplants 50 metastatic ovarian cancer 50 Celiac disease affects 50 histological subtype 50 carcinoid tumors 50 small lymphocytic lymphoma 50 radical retropubic prostatectomy 50 lymphoma multiple myeloma 50 Minimally invasive procedures 50 lung pancreatic 50 Renal Cell Carcinoma RCC 50 coronary angiography 50 obstructed bile duct 50 Cojocaru correspondent 50 rebleeding 50 enucleation 50 dysplastic lesions caused 50 chronic lyme 50 rectal cancers 50 x ray mammography 50 imipenem 50 varices 50 ICD implants 50 IV NSCLC 50 pancreatic prostate 50 donor nephrectomy 50 cancerous testicle 50 invasive lobular carcinoma 50 ovarian hyperstimulation syndrome OHSS 50 chemotherapeutic regimens 50 pulmonary dysfunction 50 cirrhosis liver failure 50 stented arteries 50 Avandia Actos 50 metastatic brain tumor 50 pre cancerous growths 50 postoperative complication 50 BRCA2 mutation carriers 50 intensive statin therapy 50 surgical revascularization 50 BRAF gene mutations 50 node dissection 50 NOMID 50 mucinous 50 Fibroid tumors 50 metastatic breast 50 advanced SCCHN 50 radiolabeled TM# 50 infiltrating ductal carcinoma 50 recurrent DVT 50 nodal metastases 50 Carcinoid tumors 50 radiation therapy SBRT 50 Rebif multiple sclerosis 50 ALT flares 50 localized prostate cancer 50 acute aortic dissection 50 thymic carcinoma 50 selenium intake 50 intracapsular 50 myelomas 50 Cystectomy 50 dose ionizing radiation 50 fallopian tube carcinoma 50 glaucoma sufferers 50 HER2 expressing 50 MALT lymphoma 50 HER2 positive metastatic 50 castration resistant hormone refractory 50 postoperative complications 50 adenocarcinoma 50 Folic acid supplements 50 psychological counseling Carstoiu 50 allogeneic transplants 50 taxane therapy 50 laparascopic 50 uterus fallopian tubes